• Mental Health
  • Independent mental health service

Psychiatry-UK

Overall: Good read more about inspection ratings

3B Fore Street, Camelford, PL32 9PG 0330 124 1980

Provided and run by:
Psych-UK Limited

All Inspections

During an assessment of Community-based mental health services for adults of working age

We carried out an announced comprehensive inspection at the registered location for Psychiatry UK on 23 January and completed remote inspection activity on 23-24 and 27-28 January 2025. We announced the inspection so that we had access to the evidence we needed to make a judgement and so that we could speak with staff while on site.

Psychiatry UK provides consultant-led mental health care and treatment for adults living with attention deficit hyperactivity disorder (ADHD) and other conditions such as autism spectrum disorder (ASD) and mood disorders. A team of prescribing nurses provide titration treatment. ADHD care is provided to NHS patients through commissioned contracts, some of which operate on a ‘right to choose’ basis and the service provides a range of mental health services to private patients. Right to choose is a national initiative that enables patients to opt for a specific service or provider once they are referred to a specialty by a General Practitioner (GP) or other NHS professional.

The service also provides online remote assessment and titration services for children and young people (CYP) living with attention deficit hyperactivity disorder (ADHD) through NHS child and adolescent mental health services (CAMHS) contracts. Commissioned services formed part of wider clinical pathways. The service provides CYP care to patients aged from 6 years old to 18 years old. While there is no formal transitional care pathway in place where patients still require care when they become 18 years old, the service liaises with NHS commissioners to arrange continuity of care.

At the time of our inspection, Psychiatry UK had over 90,000 patients aligned to their service either at the point of referral, on waiting lists for assessment, or receiving treatment following a diagnosis.

During an assessment of Community-based mental health services for adults of working age

We carried out an announced comprehensive inspection at the registered location for Psychiatry UK on 23 January and completed remote inspection activity on 23-24 and 27-28 January 2025. We announced the inspection so that we had access to the evidence we needed to make a judgement and so that we could speak with staff while on site.

Psychiatry UK provides consultant-led mental health care and treatment for adults living with attention deficit hyperactivity disorder (ADHD) and other conditions such as autism spectrum disorder (ASD) and mood disorders. A team of prescribing nurses provide titration treatment. ADHD care is provided to NHS patients through commissioned contracts, some of which operate on a ‘right to choose’ basis and the service provides a range of mental health services to private patients. Right to choose is a national initiative that enables patients to opt for a specific service or provider once they are referred to a specialty by a General Practitioner (GP) or other NHS professional.

The service also provides online remote assessment and titration services for children and young people (CYP) living with attention deficit hyperactivity disorder (ADHD) through NHS child and adolescent mental health services (CAMHS) contracts. Commissioned services formed part of wider clinical pathways. The service provides CYP care to patients aged from 6 years old to 18 years old. While there is no formal transitional care pathway in place where patients still require care when they become 18 years old, the service liaises with NHS commissioners to arrange continuity of care.

At the time of our inspection, Psychiatry UK had over 90,000 patients aligned to their service either at the point of referral, on waiting lists for assessment, or receiving treatment following a diagnosis.

During an assessment of Specialist community mental health services for children and young people

We carried out an announced comprehensive inspection at the registered location for Psychiatry UK on 23 January 2025 and completed remote inspection activity on 23-24 and 27-28 January 2025. We announced the inspection so that we had access to the evidence we needed to make a judgement and so that we could speak with staff while on site.

The service provides online remote assessment and titration services for children and young people (CYP) living with attention deficit hyperactivity disorder (ADHD) and Autistic Spectrum Disorder (ASD) and other mental health conditions through NHS child and adolescent mental health services (CAMHS) contracts. The CYP service provides care to young people between the ages of 6 and 18 years. While there is no formal transitional care pathway in place where young people still require care when they become 18 years old, the service liaises with NHS commissioners to arrange continuity of care.

Psychiatry UK also provides consultant-led mental health care and treatment for adults living with attention deficit hyperactivity disorder (ADHD) and other conditions such as autism spectrum disorder and mood disorders. A team of prescribing nurses to titrate people’s medicines. ADHD care is provided to NHS patients through commissioned contracts, some of which operate on a ‘right to choose’ basis and the service provides a range of mental health services to private patients. Right to choose is a national initiative that enables patients to opt for a specific service or provider once they are referred to a speciality by a GP or other NHS professional.

At the time of our inspection, Psychiatry UK had over 90,000 patients aligned to their service either at the point of referral, on waiting lists for assessment, or receiving treatment following a diagnosis.

During an assessment of Specialist community mental health services for children and young people

We carried out an announced comprehensive inspection at the registered location for Psychiatry UK on 23 January 2025 and completed remote inspection activity on 23-24 and 27-28 January 2025. We announced the inspection so that we had access to the evidence we needed to make a judgement and so that we could speak with staff while on site.

The service provides online remote assessment and titration services for children and young people (CYP) living with attention deficit hyperactivity disorder (ADHD) and Autistic Spectrum Disorder (ASD) and other mental health conditions through NHS child and adolescent mental health services (CAMHS) contracts. The CYP service provides care to young people between the ages of 6 and 18 years. While there is no formal transitional care pathway in place where young people still require care when they become 18 years old, the service liaises with NHS commissioners to arrange continuity of care.

Psychiatry UK also provides consultant-led mental health care and treatment for adults living with attention deficit hyperactivity disorder (ADHD) and other conditions such as autism spectrum disorder and mood disorders. A team of prescribing nurses to titrate people’s medicines. ADHD care is provided to NHS patients through commissioned contracts, some of which operate on a ‘right to choose’ basis and the service provides a range of mental health services to private patients. Right to choose is a national initiative that enables patients to opt for a specific service or provider once they are referred to a speciality by a GP or other NHS professional.

At the time of our inspection, Psychiatry UK had over 90,000 patients aligned to their service either at the point of referral, on waiting lists for assessment, or receiving treatment following a diagnosis.

During an assessment of the hospital overall

Psychiatry UK provides remote, consultant-led mental health care for adults and children with ADHD, autism spectrum disorder, and mental health conditions. At the time of inspection, the service supported over 90,000 patients across various stages of referral, assessment, and treatment. The inspection found that patients generally received safe, effective, and person-centred care.

The provider had strong systems in place to manage risk and safeguard patients. Staff used structured risk assessments and innovative AI tools to monitor patients and prioritise care. Safeguarding processes were well embedded, and staff were confident in raising concerns. 

Medicines were prescribed safely, care and treatment followed national guidance, and staff used structured assessments supported by digital tools. Patients were supported to manage their health and wellbeing, and feedback was used to improve services. Staff worked well together and communicated effectively with external partners.

Patients described staff as kind, respectful, and responsive to their needs. The service made reasonable adjustments for neurodiverse patients. Most patients felt involved in their care and supported throughout their journey.

Leaders were visible, knowledgeable, and committed to continuous improvement. Governance systems were effective, and there was a strong culture of openness, learning, and innovation. Staff felt valued and supported, and the provider had invested in workforce development and technology to meet growing demand.